Association of HLA mismatch with death with a functioning graft after kidney transplantation: A collaborative transplant study report

American Journal of Transplantation

Volumn 12, Issue 11, 2012, Pages 3031-3038

  Opelz, G ^a   Dohler B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular disease; death; HLA matching; infection; kidney transplantation

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; DEATH; DEATH WITH A FUNCTIONING GRAFT; FEMALE; GRAFT RECIPIENT; HLA SYSTEM; HOSPITALIZATION; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; VIRUS INFECTION;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CADAVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84868152644     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04226.x     Document Type: Article

References (15)

1. Qiu J, Cai J, Terasaki PL,. Death with a functioning graft in kidney transplant recipients. In, Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles: UCLA Immunogenetics Center; 2005: 379-386.
2. Collins AJ, Foley RN, Herzog C, et al., US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57: A8, e1-e526.
3. Tapiawala SN, Tinckam KJ, Cardella CJ, et al,. Delayed graft function and the risk of death with a functioning graft. J Am Soc Nephrol 2010; 21: 153-161.
4. Chang SH, Russ GR, Chadban SJ, Campbell SB, McDonald SP,. Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 2007; 84: 611-618.
5. Meier-Kriesche HU, Arndorfer JA, Kaplan B,. Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. J Am Soc Nephrol 2002; 13: 769-772.
6. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 (Suppl 3): S1-S155.
7. Boots JM, Christiaans MH, van Hooff JP,. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: Focus on the cardiovascular risk. Drugs 2004; 64: 2047-2073.
8. Marcen R,. Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs 2009; 69: 2227-2243.
9. Opelz G, Döhler B,. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Transplantation 2009; 87: 795-802.
10. Abbott KC, Hypolite I, Poropatich RK, et al,. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001; 3: 203-211.
11. Opelz G, Döhler B,. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222-230.
12. Kasiske BL, Kukla A, Thomas D, et al,. Lymphoproliferative disorders after adult kidney transplant: Epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis 2011; 58: 971-980.
13. Opelz G, Döhler B,. Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. Transplantation 2010; 89: 567-572.
14. Opelz G, Döhler B,. Effect of human leukocyte antigen compatibility on kidney graft survival: Comparative analysis of two decades. Transplantation 2007; 84: 137-143.
15. Opelz G, Döhler B,. Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. Transplantation 2011; 91: 65-69.